Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1147998-27-3

Post Buying Request

1147998-27-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1147998-27-3 Usage

Chemical Class

Pyrrolopyridine

Core Structure

Pyrrolopyridine

Substituents

Phenylsulfonyl group at the 1 position, Pyrazol-4-yl group at the 5 position

Potential Applications

Medicinal chemistry, pharmaceutical drug development

Use as Building Block

Organic synthesis, creation of diverse chemical structures

Biological Activity

Potential usefulness in research and development in pharmaceutical and biotechnology industries

Check Digit Verification of cas no

The CAS Registry Mumber 1147998-27-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,7,9,9 and 8 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1147998-27:
(9*1)+(8*1)+(7*4)+(6*7)+(5*9)+(4*9)+(3*8)+(2*2)+(1*7)=203
203 % 10 = 3
So 1147998-27-3 is a valid CAS Registry Number.

1147998-27-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(Phenylsulfonyl)-5-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine

1.2 Other means of identification

Product number -
Other names 2-Butanone,4-hydroxy-1-(phenylsulfonyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1147998-27-3 SDS

1147998-27-3Relevant articles and documents

THERAPEUTIC COMPOUNDS

-

Page/Page column 49-50, (2009/05/30)

The present invention relates to pyrazine substituted pyrrolopyridines which are inhibitors of JAK kinases (JAKl, JAK2, JAK3 and/or TYK2) and/or PDKl and are thus useful for the treatment of myeloproliferative disorders or cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1147998-27-3